Development of evidence-based clinical practice guidelines for diabetes - The department of veterans affairs/department of defense guidelines initiative

被引:55
作者
Pogach, LM
Brietzke, SA
Cowan, CL
Conlin, P
Walder, D
Sawin, CT
机构
[1] VA New Jersey Hlth Care Syst, E Orange, NJ USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Washington VA Med Ctr, Washington, DC USA
[4] Boston VA Hlth Care Syst, Boston, MA USA
[5] Dept Vet Affairs, Off Qual & Performance, Washington, DC USA
[6] Dept Vet Affairs, Off Med Inspector, Washington, DC USA
关键词
D O I
10.2337/diacare.27.suppl_2.B82
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To describe the Veterans Affairs (VA)/Department of Defense (DOD) Clinical Practice Guidelines for diabetes and contrast selected recommendations with those of the American Diabetes Association (ADA). RESEARCH DESIGN AND METHODS - We summarize the general Structure Of the VA/DoD Guidelines and describe the rationale for recommendations issued in 2003 for glycemic control, management of hypertension, and retinopathy screening. We compare the synthesis of evidence and resulting recommendations for these content areas with the 2004 American Diabetes Association Clinical Practice Recommendations. RESULTS - The VA/DoD Guidelines and the ADA Clinical Practice Recommendations reported similar strength of evidence findings by content area, but clinical recommendations varied. The VA/DoD Guidelines and practice recommendations emphasize the use of data on absolute risk reduction from available published randomized clinical trials rather than relative risk reduction from observational analyses. The VA/DoD Guidelines employ an algorithm-based methodology to guide clinicians through a risk-stratified approach to managing individual patients rather than promoting a single standard for most or all patients without explicit consideration of competing comorbidities. CONCLUSIONS - The VA/DoD Guidelines are intended to guide diabetes care by providing Internet-ready, evidence-based annotations in algorithmic form to help clinicians set and revise individual treatment goals for their patients.
引用
收藏
页码:B82 / B89
页数:8
相关论文
共 33 条
[1]   A 4-YEAR FOLLOW-UP-STUDY ON THE INCIDENCE OF DIABETIC-RETINOPATHY IN OLDER ONSET DIABETES-MELLITUS [J].
AGARDH, E ;
AGARDH, CD ;
KOUL, S ;
TORFFVIT, O .
DIABETIC MEDICINE, 1994, 11 (03) :273-278
[2]  
*AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS15
[3]  
*AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS84
[4]  
Arauz-Pacheco Carlos, 2004, Diabetes Care, V27 Suppl 1, pS65
[5]   ASSESSING ILLNESS SEVERITY - DOES CLINICAL JUDGMENT WORK [J].
CHARLSON, ME ;
SAX, FL ;
MACKENZIE, CR ;
FIELDS, SD ;
BRAHAM, RL ;
DOUGLAS, RG .
JOURNAL OF CHRONIC DISEASES, 1986, 39 (06) :439-452
[6]   COST-EFFECTIVENESS OF STRATEGIES FOR DETECTING DIABETIC-RETINOPATHY [J].
DASBACH, EJ ;
FRYBACK, DG ;
NEWCOMB, PA ;
KLEIN, R ;
KLEIN, BEK .
MEDICAL CARE, 1991, 29 (01) :20-39
[7]   Model of complications of NIDDM .1. Model construction and assumptions [J].
Eastman, RC ;
Javitt, JC ;
Herman, WH ;
Dasbach, EJ ;
Zbrozek, AS ;
Dong, F ;
Manninen, D ;
Garfield, SA ;
CopleyMerriman, C ;
Maier, W ;
Eastman, JF ;
Kotsanos, J ;
Cowie, CC ;
Harris, M .
DIABETES CARE, 1997, 20 (05) :725-734
[8]   DIABETIC-RETINOPATHY IN MEXICAN-AMERICANS AND NON-HISPANIC WHITES [J].
HAFFNER, SM ;
FONG, D ;
STERN, MP ;
PUGH, JA ;
HAZUDA, HP ;
PATTERSON, JK ;
VANHEUVEN, WAJ ;
KLEIN, R .
DIABETES, 1988, 37 (07) :878-884
[9]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[10]   Current methods of the US Preventive Services Task Force - A review of the process [J].
Harris, RP ;
Helfand, M ;
Woolf, SH ;
Lohr, KN ;
Mulrow, CD ;
Teutsch, SM ;
Atkins, D .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2001, 20 (03) :21-35